Comparison of Quality of Recovery Between Remimazolam and Propofol Anesthesia in Patients Undergoing Arthroscopic Meniscectomy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-03-14

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to compare quality of recovery after surgery and anesthesia between patients undergoing arthroscopic meniscectomy under general anesthesia with either propofol or remimazolam based total intravenous anesthesia. This study is a randomized trial with a 50% probability of being assigned to either group. Randomization will be done by an anesthesiologist not involved in anesthesia or postoperative outcome assessment. Patients and the investigator in charge of postoperative outcomes assessment will be blinded to group allocation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Remimazolam Total Intravenous Anesthesia Under Analgesia Nociception Index-guidance

NCT05322902

Knee Osteoarthritis Total Knee Arthroplasty Remimazolam

COMPLETED NA

Effect of Nociception Level Monitoring During Remimazolam-based Total Intravenous Anesthesia on Intraoperative Opioid Requirements and Postoperative Pain

NCT05615441

Adult Patients Aged 19-64, Scheduled for Elective Arthroscopic Knee Surgery

UNKNOWN NA

Comparison of Remimazolam and Propofol for Recovery of Ambulatory Upper Airway Surgery

NCT06507202

Laryngeal Disease Pharyngeal Diseases Oral Cavity Disease +1 more

RECRUITING PHASE4

ED90 of Remimazolam Loading Dose for Sedation in Patients Under Monitored Anesthetic Care

NCT05340335

Remimazolam Orthopedic Procedures Sedatives

COMPLETED PHASE4

Comparison of IONM Between Remimazolam and Propofol

NCT04968054

Ossification Posterior Longitudinal Ligament Cervical Spondylotic Myelopathy

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Adult Patients 19 or Older Scheduled for Elective Arthroscopic Meniscectomy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Propofol

Patients receiving general anesthesia with propofol-based total intravenous anesthesia

Group Type ACTIVE_COMPARATOR

Propofol TIVA

Intervention Type DRUG

Patients will receive propofol-based TIVA with propofol and remifentanil TCI (target controlled infusion)

Remimazolam

Patients receiving general anesthesia with remimazolam-based total intravenous anesthesia

Group Type EXPERIMENTAL

Remimazolam TIVA

Intervention Type DRUG

Patients will receive remimazolam-based TIVA with remimazolam infusion and remifentanil TCI

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Propofol TIVA

Patients will receive propofol-based TIVA with propofol and remifentanil TCI (target controlled infusion)

Intervention Type DRUG

Remimazolam TIVA

Patients will receive remimazolam-based TIVA with remimazolam infusion and remifentanil TCI

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patients 19 or older, ASA class I\~III,
* scheduled for arthroscopic meniscectomy under general anesthesia and eligible for LMA use.

Exclusion Criteria

* Patient refusal,
* patients unable to read consent form, active URI or uncontrolled asthma,
* pneumonia,
* history of allergies to propofol or benzodiazepines,
* decreased liver or kidney function, heart failure of ejection fraction\<55%,
* pregnant or breastfeeding patients,
* history of substance abuse/addiction

Minimum Eligible Age

19 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No